Rheumatoid arthritis patients satisfied with switch to biosimilar adalimumab
According to a study published in Research and perspectives in pharmacology.1 Larger studies have already investigated the safety and efficacy of biosimilars in this patient population with positive results, in addition to cost benefits. “However…most of the evidence to date is based on randomized controlled trial extensions in selected patients, such as the PLANETRA and …
Rheumatoid arthritis patients satisfied with switch to biosimilar adalimumab Read More »